Your browser doesn't support javascript.
loading
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
Mesa, Ruben; Harrison, Claire; Oh, Stephen T; Gerds, Aaron T; Gupta, Vikas; Catalano, John; Cervantes, Francisco; Devos, Timothy; Hus, Marek; Kiladjian, Jean-Jacques; Lech-Maranda, Ewa; McLornan, Donal; Vannucchi, Alessandro M; Platzbecker, Uwe; Huang, Mei; Strouse, Bryan; Klencke, Barbara; Verstovsek, Srdan.
Afiliação
  • Mesa R; UT Health San Antonio Cancer Center, San Antonio, TX, USA. mesar@uthscsa.edu.
  • Harrison C; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Oh ST; Washington University School of Medicine, St. Louis, MO, USA.
  • Gerds AT; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Gupta V; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Catalano J; Monash University & Frankston Hospital, Frankston, Australia.
  • Cervantes F; Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Devos T; Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium.
  • Hus M; Medical University of Lublin, Lublin, Poland.
  • Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France.
  • Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • McLornan D; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Vannucchi AM; University of Florence and AOU Careggi, Florence, Italy.
  • Platzbecker U; Leipzig University Hospital, Leipzig, Germany.
  • Huang M; Sierra Oncology Inc, San Mateo, CA, USA.
  • Strouse B; Sierra Oncology Inc, San Mateo, CA, USA.
  • Klencke B; Sierra Oncology Inc, San Mateo, CA, USA.
  • Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 36(9): 2261-2268, 2022 09.
Article em En | MEDLINE | ID: mdl-35869266

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article